老虎证券

BUZZ-Iovance falls after Q2 revenue miss, wider loss

Reuters
08/08
BUZZ-Iovance falls after <a href="https://laohu8.com/S/QTWO">Q2</a> revenue miss, wider loss 

** Shares of drugmaker Iovance Biotherapeutics IOVA.O fall 30.7% to $1.83 in extended trading

** Co reports Q2 revenue of $60 million, falling short of analysts' average estimate of $69.79 million, according to data compiled by LSEG

** Posts Q2 loss of 33 cents, analysts expected a loss of 28 cents

** Co says it is reducing its workforce by 19% by the third quarter of this year

** IOVA reiterates total product revenue guidance within the range of $250 million to $300 million vs est of $300.18 million

** Stock down 64.3% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10